https://gsk2126458inhibitor.co....m/your-organization-
12.1% of situations and 5.5% of controls were hepatitis B surface antigen (HBsAg) seropositive. We observed significant associations between HBsAg seropositivity and oesophagus cancer (aOR[95%CI] = 1.32[1.13-1.54]), belly cancer (1.46[1.30-1.65]), hepatocellular carcinoma (HCC) (39.11[35.08-43.59]), intrahepatic and extrahepatic bile duct carcinoma (ICC and ECC) (3.83[2.58-5.67] and 1.72[1.28-2.31]), pancreatic cancer (PaC) (1.37[1.13-1.65]), non-Hodgkin lymphoma (NHL) (1